Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study
ConclusionsER-positive BC patients in Europe are increasingly prescribed ET but between-country disparities persist. Older women and women with severe comorbidity less frequently receive ET. ET omission and severe comorbidity independently predict early disease relapse.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
More News: Belgium Health | Breast Cancer | Cancer | Cancer & Oncology | Estonia Health | HER2 | Slovenia Health | Spain Health | Study | Switzerland Health | Women